127 related articles for article (PubMed ID: 35089473)
1. Mitochondria act as a key regulatory factor in cancer progression: Current concepts on mutations, mitochondrial dynamics, and therapeutic approach.
Roy S; Das A; Bairagi A; Das D; Jha A; Srivastava AK; Chatterjee N
Mutat Res Rev Mutat Res; 2024; 793():108490. PubMed ID: 38460864
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial dynamics and metastasis.
Altieri DC
Cell Mol Life Sci; 2019 Mar; 76(5):827-835. PubMed ID: 30415375
[TBL] [Abstract][Full Text] [Related]
3. Editorial: Novel therapeutic targets of gastric carcinogenesis: from basic research to drug development and clinical application.
Niu C; Ren D; Liu BL
Front Oncol; 2024; 14():1431520. PubMed ID: 38854722
[No Abstract] [Full Text] [Related]
4. Phytochemicals and mitochondria: Therapeutic allies against gastric cancer.
Zhao M; Yang Y; Nian Q; Shen C; Xiao X; Liao W; Zheng Q; Zhang G; Chen N; Gong D; Tang J; Wen Y; Zeng J
Phytomedicine; 2023 Feb; 110():154608. PubMed ID: 36586205
[TBL] [Abstract][Full Text] [Related]
5. TMEM65 promotes gastric tumorigenesis by targeting YWHAZ to activate PI3K-Akt-mTOR pathway and is a therapeutic target.
Shi L; Wang X; Guo S; Gou H; Shang H; Jiang X; Wei C; Wang J; Li C; Wang L; Zhao Z; Yu W; Yu J
Oncogene; 2024 Mar; 43(13):931-943. PubMed ID: 38341472
[TBL] [Abstract][Full Text] [Related]
6. Mechanism study of oleanolic acid derivative, K73-03, inducing cell apoptosis in hepatocellular carcinoma.
Wang J; Ma C; Tang Z; Sun Z; Qaed E; Chi X; Wang J; Jamalat Y; Geng Z; Tang Z; Yao Q
Cancer Cell Int; 2024 Jan; 24(1):17. PubMed ID: 38185661
[TBL] [Abstract][Full Text] [Related]
7. N
Tang B; Bi L; Xu Y; Cao L; Li X
Mol Biotechnol; 2023 Oct; ():. PubMed ID: 37817028
[TBL] [Abstract][Full Text] [Related]
8. Constructing a novel mitochondrial-related gene signature for evaluating the tumor immune microenvironment and predicting survival in stomach adenocarcinoma.
Chang J; Wu H; Wu J; Liu M; Zhang W; Hu Y; Zhang X; Xu J; Li L; Yu P; Zhu J
J Transl Med; 2023 Mar; 21(1):191. PubMed ID: 36915111
[TBL] [Abstract][Full Text] [Related]
9. Investigations into the impact of non-coding RNA on the sensitivity of gastric cancer to radiotherapy.
Usman M; Beilerli A; Sufianov A; Kudryashov V; Ilyasova T; Balaev P; Danilov A; Lu H; Gareev I
Front Physiol; 2023; 14():1149821. PubMed ID: 36909247
[TBL] [Abstract][Full Text] [Related]
10. Combination therapy of cisplatin and resveratrol to induce cellular aging in gastric cancer cells: Focusing on oxidative stress, and cell cycle arrest.
Rahimifard M; Baeeri M; Mousavi T; Azarnezhad A; Haghi-Aminjan H; Abdollahi M
Front Pharmacol; 2022; 13():1068863. PubMed ID: 36686661
[No Abstract] [Full Text] [Related]
11. The role of FUNDC1 in mitophagy, mitochondrial dynamics and human diseases.
Liu H; Zang C; Yuan F; Ju C; Shang M; Ning J; Yang Y; Ma J; Li G; Bao X; Zhang D
Biochem Pharmacol; 2022 Mar; 197():114891. PubMed ID: 34968482
[TBL] [Abstract][Full Text] [Related]
12. The Role of Altered Mitochondrial Metabolism in Thyroid Cancer Development and Mitochondria-Targeted Thyroid Cancer Treatment.
Dabravolski SA; Nikiforov NG; Zhuravlev AD; Orekhov NA; Mikhaleva LM; Orekhov AN
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008887
[TBL] [Abstract][Full Text] [Related]
13. Silibinin-induced mitochondria fission leads to mitophagy, which attenuates silibinin-induced apoptosis in MCF-7 and MDA-MB-231 cells.
Si L; Fu J; Liu W; Hayashi T; Mizuno K; Hattori S; Fujisaki H; Onodera S; Ikejima T
Arch Biochem Biophys; 2020 May; 685():108284. PubMed ID: 32014401
[TBL] [Abstract][Full Text] [Related]
14. Targeting mitochondria as a therapeutic anti-gastric cancer approach.
Tanprasert P; Limpakan Yamada S; Chattipakorn SC; Chattipakorn N; Shinlapawittayatorn K
Apoptosis; 2022 Apr; 27(3-4):163-183. PubMed ID: 35089473
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic potential of targeting mitochondrial dynamics in cancer.
Rodrigues T; Ferraz LS
Biochem Pharmacol; 2020 Dec; 182():114282. PubMed ID: 33058754
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial dynamics regulators: implications for therapeutic intervention in cancer.
Kumar S; Ashraf R; C K A
Cell Biol Toxicol; 2022 Jun; 38(3):377-406. PubMed ID: 34661828
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
